Navigation Links
CryoCath to Hold Third Quarter 2008 Conference Call and Webcast
Date:7/30/2008

http://www.cryocath.com

Toronto Stock Exchange Symbol: CYT

MONTREAL, July 30 /PRNewswire-FirstCall/ - CryoCath (TSX: CYT), will hold a conference call to discuss its third quarter 2008 financial results at 9:00 a.m. (Eastern Time) on Tuesday, August 5, 2008. The call will be hosted by Mr. Jan Keltjens, President and CEO and Mrs. Ginette Gagne, CFO. The Company will report its results in a press release to be issued at 7:00 a.m on Tuesday, August 5.

DATE: Tuesday, August 5, 2008

TIME: 9:00 a.m., Eastern Time

DIAL IN NUMBER: 416-644-3427 or 1-866-250-4892

TAPED REPLAY: 416-640-1917 or 1-877-289-8525

REFERENCE NUMBER: 21279395 followed by the number sign

WEBCAST: A live audio webcast of the call will be available

at http://www.cryocath.com. Webcast attendees are welcome

to listen to the conference in real-time or

on-demand at their convenience. The webcast will be

archived for 365 days. Please connect to this

website at least 15 minutes prior to the conference

call to ensure adequate time for any software

download that may be needed to hear the webcast.

A question and answer session will follow, at which time the operator will direct participants as to the correct procedure for submitting questions.

About CryoCath

CryoCath - http://www.cryocath.com - is a medical technology company that leads the world in cryotherapy products to treat cardiac arrhythmias. With a priority focus on providing physicians with a complete solution of catheter products to treat cardiac arrhythmias, CryoCath has multiple products approved in the U.S., across Europe and several ROW countries. The Company is developing additional products to expand its pipeline of products to treat cardiac arrhythmias.

This press release includes "forward-looking statements" that are subject to risks and uncertainties, including with respect to the timing of regulatory trials and their outcome. For information identifying legislative or regulatory, economic, climatic, currency, technological, competitive and other important factors that could cause actual results to differ materially from those anticipated in the forward looking statements, see CryoCath's annual report available at http://www.sedar.com under the heading Risks and Uncertainties in the Management's Discussion and Analysis section.


'/>"/>
SOURCE CryoCath Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CryoCath Appoints Vice President, Europe
2. CryoCath Presents at Prestigious Heart Rhythm Society Meeting
3. CryoCath Announces Fiscal 2008 Second Quarter Results
4. CryoCath to Hold Second Quarter 2008 Conference Call and Webcast
5. CryoCath Reports Data Presented at the 74th Annual Meeting of the German Cardiac Society
6. CryoCath Introduces Arctic Front in Australia
7. CryoCath Appoints New Chief Financial Officer
8. CryoCath Technologies notice of annual meeting
9. CryoCath Announces Fiscal 2008 First Quarter Results
10. CryoCath Provides Update on Patent Infringement Lawsuit
11. CryoCath to Hold First Quarter 2008 Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... NJ (PRWEB) , ... January ... ... the specialty pharmacy industry’s leading journal and most-read publication among specialty pharmacists ... University Medical Center through its Strategic Alliance Partnership (SAP) program, announced Brian ...
(Date:1/18/2017)... Palm Beach, FL (PRWEB) , ... January 18, 2017 , ... ... as a fund raiser for Smile Train, an international charity that provides free surgery ... a hobby of mine and in the past I have run to support the ...
(Date:1/18/2017)... , ... January 18, 2017 , ... The Portee Insurance ... families and business owners in central Maryland and the DC region, is inaugurating a ... kills 787,000 people nationally every year, making it the #1 killer in America. However, ...
(Date:1/18/2017)... ... January 18, 2017 , ... At Hallmark Nameplate, their ... that they have achieved certification to ISO 13485. This certification is another way they ... to date products and services that they need. , The ISO 13485 Certification is ...
(Date:1/18/2017)... ... January 18, 2017 , ... Catalent ... for drugs, biologics and consumer health products, today announced that Mr. Michael Merges, ... upcoming WCBP Conference, to be held at the Mayflower Hotel, Washington DC, on ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 2017   Synthetic Biologics, Inc. (NYSE ... designed to preserve the microbiome to protect and ... to initiate a Phase 2b/3 adaptive pivotal trial ... lactone designed to reduce methane production by certain ... to treat the underlying cause of irritable bowel ...
(Date:1/18/2017)...  Aprima Medical Software, a leading provider of ... and revenue cycle management (RCM) solutions for medical ... reseller Healthcare Data Solutions (HDS) of Coral Cables, ... assume full support for HDS,s customers, which include ... 15 states. Financial terms were not disclosed. ...
(Date:1/18/2017)... Jan. 18, 2017   Spotlight Innovation Inc. ... Therapeutics plans, in the second quarter of 2017, ... roll-on intended to provide relief from chronic pain, ... analgesics. It was developed under a licensing agreement ... products derived from snake venom. Additionally, Caretta Therapeutics ...
Breaking Medicine Technology: